Last reviewed: June 15, 2026
Last updated: June 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
You do not buy compounded semaglutide the way you buy a supplement — it is dispensed, not sold, by a state-licensed pharmacy against a prescription written for you by a licensed clinician after an evaluation. Any source offering it without that sequence is operating outside the system that makes the contents of the vial identifiable. The FDA is unusually direct on this point, urging consumers to purchase prescription medicines only from state-licensed pharmacies and publishing a specific list of telehealth warning signs for this drug class. Knowing what compounded semaglutide is — and is not — is the part that makes the sourcing question answerable.
What You Are Actually Obtaining
Compounded semaglutide is prepared by a licensed pharmacy pursuant to a prescription for an individual patient. The FDA states that compounded drugs are not FDA approved, which means the agency does not review them for safety, effectiveness or quality before they are marketed, and that compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved drug.
It is not a generic. Neither Ozempic nor Wegovy has an FDA-approved generic, and the FDA specifically lists claims that a compounded drug is the same as an FDA-approved drug among its telehealth red flags. A provider who uses that language has already failed a test the agency published.
The Non-Negotiable Sequence
A licensed clinician evaluates you. A prescription is written. A state-licensed pharmacy compounds and dispenses it. The FDA states the same sequence in its own guidance: patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy.
Every step in that sequence is verifiable. Clinician licensure is checkable through state medical and nursing boards. Pharmacy licensure is checkable through state boards of pharmacy. If a seller cannot survive that verification, the transaction is not one you want completed.
The FDA's Published Red Flags
The agency's statement on unapproved GLP-1 drugs lists warning signs concretely: a company that claims the compounded drug is the same as an FDA-approved drug; that offers deep discounts or prices that seem too good to be true; that sends medicine looking different from what was previously received or pictured, or arriving in broken packaging or without instructions for use; that does not require screening and a prescription from a licensed clinician; that has no clinician available to answer questions afterward; that makes spelling errors on the label or lists incorrect pharmacy addresses; or that names a pharmacy you suspect is fraudulent.
That last item is not hypothetical. The FDA reports fraudulent compounded semaglutide and tirzepatide marketed in the U.S. with false label information, in some cases naming compounding pharmacies that do not exist, and in others naming a real licensed pharmacy that did not compound the product.
Ingredient and Handling Questions Worth Asking
Two specific issues the FDA has raised are worth putting directly to any provider. First, salt forms: the agency is aware that some semaglutide products sold by compounders may be salt forms such as semaglutide sodium or semaglutide acetate, states these are different active ingredients from the one used in approved drugs, and says it is not aware of any lawful basis for their use in compounding.
Second, cold chain: injectable GLP-1 drugs require refrigeration per their package inserts, and the FDA has received complaints that some compounded GLP-1 products arrived warm or with inadequate ice packs. Its recommendation is not to use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration.
What Is Never a Legitimate Source
Products labeled "for research purposes" or "not for human consumption" sold directly to consumers are the clearest case. The FDA has warned companies illegally selling unapproved products containing semaglutide or tirzepatide under those labels while supplying dosing instructions to consumers and urges consumers not to purchase them.
The agency has also documented counterfeit Ozempic in the U.S. market and established an import alert covering GLP-1 active pharmaceutical ingredients with potential quality concerns. Cagrilintide, it notes, cannot be used in compounding under federal law and have not been found safe and effective for any condition.
Where PlexusDx Fits
PlexusDx offers prescription GLP-1 protocols in all 50 states through async intake or a live consult, with no membership and no insurance requirement. Prescriptions are written by licensed clinicians and medications are dispensed from licensed 503A compounding pharmacies following quality and safety standards.
PlexusDx does not describe compounded semaglutide as a generic or as equivalent to an approved brand, because it is neither. That is the standard worth applying to any provider you are evaluating: not whether they promise the most, but whether what they say survives comparison with the FDA's own published statements.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Can compounded semaglutide be bought without a prescription?
No legitimate route exists. Compounded semaglutide is dispensed by a state-licensed pharmacy against a prescription written for an individual patient by a licensed clinician after an evaluation. The FDA instructs patients to obtain a prescription from their doctor and fill it at a state-licensed pharmacy, and lists services that do not require screening and a prescription among its telehealth red flags.
How do I verify a compounding pharmacy?
State boards of pharmacy license pharmacies and publish verification tools covering both in-state and non-resident pharmacies shipping into the state. Clinician licensure is similarly verifiable through state medical and nursing boards. The FDA urges consumers to purchase only from state-licensed pharmacies and publishes guidance on buying medicine over the internet.
What are salt forms and why do they matter?
The FDA is aware that some semaglutide products sold by compounders may be salt forms including semaglutide sodium and semaglutide acetate. The agency states these are different active ingredients from the one used in the approved drugs, that it does not have information on whether they share the same chemical and pharmacologic properties, and that it is not aware of any lawful basis for their use in compounding.
What should I do if a shipment arrives warm?
The FDA recommends not using any injectable GLP-1 drug that arrives warm or with insufficient refrigeration, since improper storage during shipping can affect the drug's quality. Injectable GLP-1 drugs require refrigeration as indicated in their package inserts. Contact the dispensing pharmacy and the prescriber rather than making a judgment call about a product whose handling cannot be verified.
Are products labeled "research use only" a cheaper option?
They are not a legitimate option at all. The FDA has warned companies illegally selling unapproved products containing semaglutide or tirzepatide falsely labeled "for research purposes" or "not for human consumption" while supplying dosing instructions to consumers and urges consumers not to purchase them because they are of unknown quality and may be harmful.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Semaglutide and Tirzepatide: Understanding Risks If You Have Gallstones
Does Ozempic Help With Fluid Retention?